BridgeMD
New treatment option for Hip Fractures
Official title What Laxative Should be Used After Hip Fracture Surgery?
ClinicalTrials.gov ID: NCT06455813
What this study is testing
What is Bisacodyl?
Bisacodyl is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for hip fractures.
Also referred to as Dulcolax.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- To conduct a randomized clinical trial to determine how best to prevent constipation after hip fracture surgery using laxatives.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 to 110
You may be able to join if
- Acute hip fracture surgery patients from one of two orthopedic departments from hospitals in the Southern Region of Denmark.
- Age≥ 65 years
- The patients should be able to speak and understand Danish.
You likely can't join if
- Patients:
- with known chronic constipation (defined from Wexner constipation score)
- with known use of laxatives at admission
- who participate in other similar clinical studies
- who is terminally ill
- who is restraint
See the full eligibility criteria
- Acute hip fracture surgery patients from one of two orthopedic departments from hospitals in the Southern Region of Denmark.
- Age≥ 65 years
- The patients should be able to speak and understand Danish.
- Patients:
- with known chronic constipation (defined from Wexner constipation score)
- with known use of laxatives at admission
- who participate in other similar clinical studies
- who is terminally ill
- who is restraint
- who is in isolation
- with severe heart disease defined as New York Heart Association (NYHA) III og IV
- with severe chronically inflammatory bowel disease
- with acute abdominal surgical conditions, eg. ileus, obstruction or perforation
- with dysphagia where the patient can not swallow tablets/oral liquids
- with toxic megacolon
- with gastric emptying disorder
- with severe electrolyte disorder (P-kalium: \< 2.5 mmol/l og P-natrium: \<125 mmol/l)
- Allergies to the ingredients
- Pregnant women can not be included but the women are expected to be postmenopausal why pregnancy test are not performed
The study team makes the final eligibility decision.
Where it's taking place
- Kolding, Denmark
- Svendborg, Denmark
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years to 110 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kolding, Denmark; Svendborg, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.